38 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
then in office, even if less than a quorum;
require that any action to be taken by our stockholders must be effected at a duly called annual or special … meeting of stockholders and not be taken by written consent or electronic transmission;
provide that stockholders seeking to present proposals before
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
a quorum;
require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders … such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders
424B4
CGTX
Cognition Therapeutics Inc
8 Jan 24
Prospectus supplement with pricing info
4:11pm
action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent … , the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written
S-3
htkoopj3fxgi
23 Dec 22
Shelf registration
4:16pm
424B4
g0t9 pdft4pkq2jvif
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
9wcoua349v0806nuf6ht
20 Oct 22
Draft registration statement
12:00am
10-K
EX-4.1
sc4a2 l39xf1l
30 Mar 22
Annual report
7:40am
10-K
69oi203
30 Mar 22
Annual report
7:40am
10-Q
apuwtjdj
17 Nov 21
Quarterly report
5:15pm
8-K
kqmi15m emquqzhsk2ks
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
8-K
EX-3.2
8nozymk
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
8-K
EX-3.1
cwwhbmrtp9njn f9s
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
q36xedideum
12 Oct 21
Prospectus supplement with pricing info
4:11pm